![Hendrik Zonnenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik Zonnenberg
Directeur en chef des Investissements chez Multifund BV
Postes actifs de Hendrik Zonnenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Multifund BV
![]() Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Directeur en chef des Investissements | - | - |
ISA Pharmaceuticals BV
![]() ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Hendrik Zonnenberg
Anciens postes connus de Hendrik Zonnenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
ING Bank NV (Broker)
![]() ING Bank NV (Broker) Investment Banks/BrokersFinance ING Bank NV (Broker) (ING Bank-Broker) is the broker-dealer division of ING Bank NV, an investment bank headquartered in Amsterdam, Netherlands. It is a wholly-owned subsidiary of ING Groep N.V. (AMS: INGA; NYSE: ING), a Dutch multinational banking and financial services corporation. The firm was founded in 1991 through the merger of Nationale-Nederlanden and NMB Postbank Groep. ING Bank-Broker provides brokerage services to institutions, large corporations, and medium-sized companies. | Analyst-Equity | 18/10/2005 | 18/10/2005 |
Formation de Hendrik Zonnenberg
University of Groningen | Graduate Degree |
Statistiques
Internationale
Pays-Bas | 5 |
Opérationnelle
Analyst-Equity | 1 |
Chief Investment Officer | 1 |
Director/Board Member | 1 |
Sectorielle
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
ING Bank NV (Broker)
![]() ING Bank NV (Broker) Investment Banks/BrokersFinance ING Bank NV (Broker) (ING Bank-Broker) is the broker-dealer division of ING Bank NV, an investment bank headquartered in Amsterdam, Netherlands. It is a wholly-owned subsidiary of ING Groep N.V. (AMS: INGA; NYSE: ING), a Dutch multinational banking and financial services corporation. The firm was founded in 1991 through the merger of Nationale-Nederlanden and NMB Postbank Groep. ING Bank-Broker provides brokerage services to institutions, large corporations, and medium-sized companies. | Finance |
Multifund BV
![]() Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Finance |
ISA Pharmaceuticals BV
![]() ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Bourse
- Insiders
- Hendrik Zonnenberg
- Expérience